On 10/9/12 9:17 PM, Liu Shiyong wrote:
Justin,

  Single mutation for four residue. The number of mutants is 4x19=76
Of course , that is a tiny peptide library.


Of course one can design many different mutants with a 4-residue peptide (far more than 76 in fact, considering all possible combinations of all 20 amino acids), but I do not believe that is the intent of the OP here. Referring to the original post:

http://lists.gromacs.org/pipermail/gmx-users/2012-October/075182.html

It seems that 4 total simulations are intended (perhaps 4 simulations with replicates).

-Justin

On Wed, Oct 10, 2012 at 9:06 AM, Justin Lemkul <[email protected]> wrote:


On 10/9/12 8:43 PM, Liu Shiyong wrote:

Hi,

Your expectation from MD is too much than reality.

Peptide design is an open problem. Lots of elegant protocols are
available. However, to my understanding, the core problem is still
about protein-peptide docking and scoring. MD simulation only helps on
some special cases. It is impossible that MD simulation is used to for
screening peptide library.


I would hardly call 4 different mutants a library.  Plenty of methods exist
to enhance the sampling of such systems and have been used to great effect.
Computationally expensive to pull off properly?  Yes.  Impossible?  In this
case, I would say no.

-Justin



On Thu, Oct 4, 2012 at 9:16 PM, rama david <[email protected]>
wrote:

Thank you  for reply,
   I read the recently published article in Biochemistry.
They worked on the same receptor that I am working.
( as I mention in my previous mail)
They used NAMD software and I am using gromacs.
They sliced the  receptor binding site and used the the solid support
to the binding site and did simulation.
                 So if I freeze  the group is it will ok ??
Is it possible in gromacs to fix the residue on solid immobilized
surface.
If it is how to do it??

my question is How to decide which group are remove and which group
should
keep in simulation.????

thank you in advance
Thank you for giving your valuable time and advice to me.

With best wishes and regards,
Rama david






On Thu, Oct 4, 2012 at 6:11 PM, Thomas Evangelidis
<[email protected]>wrote:

I don't think AutoDock and Vina are suitable for peptide docking. I
would
first try the FlexPepDocking module of Rosetta which does ab initio
folding
of the peptide on the receptor, while moving the side-chains of the
protein
but leaves its backbone intact. Rosetta implements a knowledge-based
scoring, which has been specifically designed for this task and is as
fast
as Vina or AutoDock.

I would first do that and if I wouldn't get any reasonable results then
I
would move to MD starting from the top scored protein-peptide complexes
created by Rosetta.

Thomas


On 4 October 2012 15:08, rama david <[email protected]> wrote:

Hi francesco,

Thank you For reply.
I did docking but the result are not so impressive.
I used vina and autodock.
I also did virtual screening in autodock but the result are not upto
the
mark.

Is the freezing of group can affect my system?? How much efficiency I
get
by these work??
As these group are going to freeze in four simulation so if it affect
one
ligand it  affect other
ligand also.

I read article that did the work like me ,
they sliced the binding residues and  used the inert solid sphere to
support binding residues
instead of the freezing group other group.

I think both way should have same effect..Am I right or wrong??

If you have any other way please suggest it..

With best wishes and regards
Rama david


On Thu, Oct 4, 2012 at 5:07 PM, francesco oteri
<[email protected]>wrote:

Hi,
as far as I know, freezing just set velocities to 0 so you gain
nothing
freezing atoms.

By the way, have you tried docking? It takes into account multiple
conformation and
orientation of the peptide and, depending upon the implemented

algorithm,

also
protein sidechain orientation.

Francesco


2012/10/4 rama david <[email protected]>

thank you Justin for reply.

I dont know about long range interactions.
But as I freeze the group I think it will improve my computational

speed.

So is there any way to find out or decide which group should be
freeze, and which group should affect my interaction most probably??

Should I do Essential Dynamics ??? or Principle component analysis

???


Would you suggest me any general protocol for such work??

Thank you in Advance


With Best Wishes and regards.
Rama David

On Thu, Oct 4, 2012 at 3:57 PM, Justin Lemkul <[email protected]>

wrote:




On 10/4/12 2:01 AM, rama david wrote:

Hi gromacs Friends,
               I want to do peptide-receptor ( Protein) interaction
study.Receptor consist a single chain.
Peptide is made up  of  4 amino acids. I know the interaction

pattern

of

peptide and receptor.
I plan to mutate single residue each at a time and  run 4

simulation .

So I will have the 4 different simulation that contain the mutated
residues
and the wild one.


Then afterward from the interaction energy I want to select the

peptide

which is showing
stronger interaction than others.

As  mention I know the binding site, If I freeze the remaining

portion

in

receptor
that not involved in binding , Is it going to affect my screening

process

???


Potentially.  Do you know that the binding interactions and the

mutations

will only perturb local residues?  Do you know that there are no

long-range

motions to be considered?

I think you gain very little by freezing portions of the system,

and

risk

more than you gain.

-Justin

--
==============================**==========

Justin A. Lemkul, Ph.D.
Research Scientist
Department of Biochemistry
Virginia Tech
Blacksburg, VA
jalemkul[at]vt.edu | (540) 231-9080
http://www.bevanlab.biochem.**vt.edu/Pages/Personal/justin<

http://www.bevanlab.biochem.vt.edu/Pages/Personal/justin>


==============================**==========
--
gmx-users mailing list    [email protected]
http://lists.gromacs.org/**mailman/listinfo/gmx-users<

http://lists.gromacs.org/mailman/listinfo/gmx-users>

* Please search the archive at http://www.gromacs.org/**
Support/Mailing_Lists/Search<

http://www.gromacs.org/Support/Mailing_Lists/Search>before posting!

* Please don't post (un)subscribe requests to the list. Use the www
interface or send it to [email protected].
* Can't post? Read http://www.gromacs.org/**Support/Mailing_Lists<

http://www.gromacs.org/Support/Mailing_Lists>


--
gmx-users mailing list    [email protected]
http://lists.gromacs.org/mailman/listinfo/gmx-users
* Please search the archive at
http://www.gromacs.org/Support/Mailing_Lists/Search before posting!
* Please don't post (un)subscribe requests to the list. Use the
www interface or send it to [email protected].
* Can't post? Read http://www.gromacs.org/Support/Mailing_Lists




--
Cordiali saluti, Dr.Oteri Francesco
--
gmx-users mailing list    [email protected]
http://lists.gromacs.org/mailman/listinfo/gmx-users
* Please search the archive at
http://www.gromacs.org/Support/Mailing_Lists/Search before posting!
* Please don't post (un)subscribe requests to the list. Use the
www interface or send it to [email protected].
* Can't post? Read http://www.gromacs.org/Support/Mailing_Lists

--
gmx-users mailing list    [email protected]
http://lists.gromacs.org/mailman/listinfo/gmx-users
* Please search the archive at
http://www.gromacs.org/Support/Mailing_Lists/Search before posting!
* Please don't post (un)subscribe requests to the list. Use the
www interface or send it to [email protected].
* Can't post? Read http://www.gromacs.org/Support/Mailing_Lists




--

======================================================================

Thomas Evangelidis

PhD student
University of Athens
Faculty of Pharmacy
Department of Pharmaceutical Chemistry
Panepistimioupoli-Zografou
157 71 Athens
GREECE

email: [email protected]

            [email protected]


website: https://sites.google.com/site/thomasevangelidishomepage/
--
gmx-users mailing list    [email protected]
http://lists.gromacs.org/mailman/listinfo/gmx-users
* Please search the archive at
http://www.gromacs.org/Support/Mailing_Lists/Search before posting!
* Please don't post (un)subscribe requests to the list. Use the
www interface or send it to [email protected].
* Can't post? Read http://www.gromacs.org/Support/Mailing_Lists

--
gmx-users mailing list    [email protected]
http://lists.gromacs.org/mailman/listinfo/gmx-users
* Please search the archive at
http://www.gromacs.org/Support/Mailing_Lists/Search before posting!
* Please don't post (un)subscribe requests to the list. Use the
www interface or send it to [email protected].
* Can't post? Read http://www.gromacs.org/Support/Mailing_Lists





--
========================================


Justin A. Lemkul, Ph.D.
Research Scientist
Department of Biochemistry
Virginia Tech
Blacksburg, VA
jalemkul[at]vt.edu | (540) 231-9080
http://www.bevanlab.biochem.vt.edu/Pages/Personal/justin

========================================

--
gmx-users mailing list    [email protected]
http://lists.gromacs.org/mailman/listinfo/gmx-users
* Please search the archive at
http://www.gromacs.org/Support/Mailing_Lists/Search before posting!
* Please don't post (un)subscribe requests to the list. Use the www
interface or send it to [email protected].
* Can't post? Read http://www.gromacs.org/Support/Mailing_Lists




--
========================================

Justin A. Lemkul, Ph.D.
Research Scientist
Department of Biochemistry
Virginia Tech
Blacksburg, VA
jalemkul[at]vt.edu | (540) 231-9080
http://www.bevanlab.biochem.vt.edu/Pages/Personal/justin

========================================
--
gmx-users mailing list    [email protected]
http://lists.gromacs.org/mailman/listinfo/gmx-users
* Please search the archive at 
http://www.gromacs.org/Support/Mailing_Lists/Search before posting!
* Please don't post (un)subscribe requests to the list. Use the www interface or send it to [email protected].
* Can't post? Read http://www.gromacs.org/Support/Mailing_Lists

Reply via email to